Belantamab Mafodotin (Belamaf) for Relapsed/Refractory Multiple Myeloma (RRMM): A Real-World Observational Study

被引：4

作者：

Hultcrantz, Malin ^{[1
]}

Kleinman, David ^{[2
]}

Vij, Ravi ^{[3
]}

Escalante, Fernando ^{[4
]}

Kotowsky, Nirali ^{[5
]}

Bitetti, Jacopo ^{[6
]}

Mackay, Christine ^{[5
]}

Boytsov, Natalie ^{[5
]}

Camadoo-O'Byrne, Leena ^{[7
]}

Germain, Guillaume ^{[8
]}

Duh, Mei Sheng ^{[9
]}

Laliberte, Francois ^{[8
]}

Mahendran, Malena ^{[8
]}

Urosevic, Ana ^{[8
]}

Lee, Hans C. ^{[10
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA

[2] Univ Rochester, Med Ctr, Flaum Eye Inst, Rochester, NY 14642 USA

[3] Washington Univ, St Louis, MO USA

[4] Univ Hosp Leon, Hematol Dept, Leon, Spain

[5] GSK, Upper Providence, PA USA

[6] GSK, Zug, Switzerland

[7] GSK, Stevenage, Herts, England

[8] Ltee, Grp Anal, Montreal, PQ, Canada

[9] Anal Grp Inc, Boston, MA USA

[10] MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-164929

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：10124 / 10126

页数：3

共 50 条

[1] Belantamab mafodotin (belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study update
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Delforge, Michel
Kotowsky, Nirali
Bitetti, Jacopo
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Powers Happ, Lindsey
Rohman, Mujib
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans C.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[2] A real-world observational study of belantamab mafodotin (belamaf) as a treatment for relapsed/refractory multiple myeloma (RRMM)
Cavo, Michele
Delforge, Michel
Dimopoulos, Meletios
Escalante, Fernando
Hultcrantz, Malin
Kleinman, David
Lee, Hans
Vij, Ravi
Kotowsky, Nirali
Camadoo-O'Byrne, Leena
Bitetti, Jacopo
D'Estrube, Tim
Fry, Mark
Vossen, Carla
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S166 - S167
[3] Real-world analysis of belantamab mafodotin (belamaf): Care patterns in relapsed/refractory multiple myeloma
Patel, Mihir
Locke, Susan C.
Falvey, Caroline
Troy, Jesse D.
Herring, Kris W.
Bolgioni-Smith, Amanda
Doherty, Allison
Elcock, Cherie Howard
Iadeluca, Laura L.
LeBlanc, Thomas William
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[4] Belantamab mafodotin for relapsed/refractory multiple myeloma: a real-world observational study update
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Delforge, Michel
Kotowsky, Nirali
Bitetti, Jacopo
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Happ, Lindsey Powers
Rohman, Mujib
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S185 - S186
[5] Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma: A Real-World Observational Study Update
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Delforge, Michel
Kotowsky, Nirali
Bitetti, Jacopo
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Happ, Lindsey Powers
Rohman, Mujib
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S504 - S504
[6] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Experience
Hultcrantz, Malin
Orozco, Jennifer
Peterson, Tim J.
Derkach, Andriy
Hassoun, Hani
Korde, Neha
Lu, Sydney X.
Mailankody, Sham
Patel, Dhwani
Shah, Urvi A.
Tan, Carlyn
Maclachlan, Kylee H.
Chung, David J.
Landau, Heather J.
Shah, Gunjan L.
Lahoud, Oscar B.
Scordo, Michael
Landgren, Ola
Giralt, Sergio
Lesokhin, Alexander
[J]. BLOOD, 2021, 138
[7] Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
Shragai, Tamir
Magen, Hila
Lavi, Noa
Gatt, Moshe
Trestman, Svetlana
Zektser, Miri
Ganzel, Chezi
Jarchowsky, Osnat
Berger, Tamar
Tadmor, Tamar
Leiba, Merav
Hertzog-Tzarfaty, Katrin
Horowitz, Netanel
Shapira, Michael
Varssano, David
Berger, Yoav
Frenkel, Shahar
Krauthammer, Mark
Avivi, Irit
Luttwak, Efrat
Cohen, Yael C.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (01) : 45 - 53
[8] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Single Center Experience
Hultcrantz, Malin
Derkach, Andriy
Hassoun, Hani
Korde, Neha
Maclachlan, Kylee H.
Mailankody, Sham
Patel, Dhwani
Shah, Urvi A.
Tan, Carlyn
Akhlaghi, Theresia
Hamadeh, Issam S.
Chung, David J.
Lahoud, Oscar B.
Landau, Heather
Scordo, Michael
Shah, Gunjan L.
Giralt, Sergio A.
Lesokhin, Alexander M.
Usmani, Saad
[J]. BLOOD, 2022, 140 : 7246 - 7248
[9] Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)
Adrián Alegre
Gonzalo Benzo
Rafael Alonso
Joaquín Martínez-López
Ana Jimenez-Ubieto
Clara Cuéllar
Elham Askari
Elena Prieto
Concepción Aláez
Beatriz Aguado
Alberto Velasco
Isabel Krsnik
Ana Bocanegra
Laura Llorente
Cristina Muñoz-Linares
Ana Morales
Eugenio Giménez
Rebeca Iglesias
Carmen Martínez-Chamorro
Aránzazu Alonso
Carmen Jiménez-Montes
María J. Blanchard
[J]. Oncology and Therapy, 2023, 11 : 83 - 96
[10] Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)
Alegre, Adrian
Benzo, Gonzalo
Alonso, Rafael
Martinez-Lopez, Joaquin
Jimenez-Ubieto, Ana
Cuellar, Clara
Askari, Elham
Prieto, Elena
Alaez, Concepcion
Aguado, Beatriz
Velasco, Alberto
Krsnik, Isabel
Bocanegra, Ana
Llorente, Laura
Munoz-Linares, Cristina
Morales, Ana
Gimenez, Eugenio
Iglesias, Rebeca
Martinez-Chamorro, Carmen
Alonso, Aranzazu
Jimenez-Montes, Carmen
Blanchard, Maria J.
[J]. ONCOLOGY AND THERAPY, 2023, 11 (01) : 83 - 96

← 1 2 3 4 5 →